Merck | MRK - Current Assets


Merck reported EUR14.16B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Adidas EUR 12.28B 303M Mar/2026
Adyen EUR 11.69B 1.7B Dec/2025
Akzo Nobel EUR 7.53B 1.47B Mar/2026
Alcon AG USD 6.62B 171M Mar/2026
Amadeus IT EUR 2.32B 162.6M Mar/2026
Amarin USD 626.02M 23.87M Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
Covestro EUR 5.91B 259M Dec/2025
Danone EUR 13.23B 332M Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Henkel EUR 10.07B 268M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Infineon EUR 10.52B 693M Mar/2026
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Linde USD 12.75B 574M Mar/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Philips EUR 9.78B 148M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
UCB EUR 6.05B 733M Dec/2025